We are pleased to announce our participation in i2.JP, an initiative launched by AstraZeneca to connect parties such as start-ups, healthcare professionals, local governments, academia and private companies. i2.JP aims to joinly solve problems in the healthcare sector and to come up with practical and optimal solutions.
HIROTSU BIO SCIENCE Corporation is proud to announce the opening of a store on Tmall Global, the largest cross-border EC platform in China opera . . .2023.08.22
Hirotsu Bio Science Inc. (Headquarters: Chiyoda-ku, Tokyo, Representative Director: Takaaki Hirotsu) has signed a memorandum of understanding wi . . .2023.06.13
On Thursday, March 16, "DAVOS 2023 DEBRIEFING" was held by the Consulate of Switzerland in Osaka.Our CMO/CGO, Shunsuke Mizushima, was invited as . . .2023.03.20